United States Department of Justice v. Daniel Chapter One

650 F. App'x 20
CourtCourt of Appeals for the D.C. Circuit
DecidedMay 18, 2016
DocketNo. 15-5155
StatusPublished
Cited by3 cases

This text of 650 F. App'x 20 (United States Department of Justice v. Daniel Chapter One) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States Department of Justice v. Daniel Chapter One, 650 F. App'x 20 (D.C. Cir. 2016).

Opinion

JUDGMENT

Per Curiam

This appeal from the order of the United States District Court for the District of Columbia was presented to the court and briefed and argued by counsel. The court has accorded the issues full consideration and has determined that they do not warrant a published opinion. See D.C. Cir. R. 36(d). It is

ORDERED AND ADJUDGED that the judgment of the District Court be affirmed.

In 2008, the Federal Trade Commission filed an administrative complaint against [22]*22Daniel Chapter One and its “Overseer,” James Feijo, which accused the defendants of using deceptive and unfair acts and practices to market dietary supplements in violation of sections 5(a) arid 12 of the Federal Trade Commission Act, 15 U.S.C. §§ 45(a), 52. More specifically, the complaint alleged that the defendants had made unsubstantiated claims about their dietary supplements’ ability to prevent, treat, and cure tumors and cancers. During the administrative proceeding that followed, the Commission found that the defendants had, in fact, violated the Act, and it issued a cease-and-desist order that became effective April 2, 2010. Among other things, the order: (1) prohibited the defendants from representing that any dietary supplement or other health-related product “prevents, treats, or cures ... any type of tumor or cancer” unless the representation was true, nonmisleading, and substantiated by “competent and reliable scientific evidence” at the time it was made; (2) prohibited the defendants from making any representation about the “efficacy, performance, or health-related benefits” of any dietary supplement or other health-related product unless the representation was true, nonmisleading, and substantiated by “competent and reliable scientific evidence” at the time it was made; and (8) required the defendants to mail a notice to certain customers, advising them that the Commission had found the defendants’ advertising claims deceptive. Daniel Chapter One, 149 F.T.C. 1574, at *3-4 (2010). The defendants subsequently petitioned this court for review.

While their petition was pending, the Department of Justice filed the present suit under sections 5(1), 13(b), and 16(a) of the FTC Act in order to obtain permanent injunctive relief; consumer redress, and civil penalties against the defendants for continued violations of the Commission’s cease-and-desist order. It also sought and obtained an order, from this court directing the defendants to comply with the Commission’s cease-and-desist order while the court completed its review. Neither action stopped the defendants’ troubling behavior. Consequently, after this court denied the defendants’ petition for review, the government requested, and in June 2011 obtained, a preliminary injunction, which again directed the defendants to comply with the Commission’s cease-and-desist order. Shortly thereafter, the government moved to hold the defendants in contempt of court for violating the district court’s injunction. Following a hearing on May 9, 2012, the district court found that the defendants were, indeed, in contempt, and it gave them two weeks to purge the contempt or face severe monetary penalties and imprisonment. Only then did the defendants appear to cease their illegal conduct.

Some months later, the district court issued a lengthy opinion finding that the defendants had repeatedly violated the Commission’s cease-and-desist order since it went into effect on April 2, 2010. See United States Department of Justice v. Daniel Chapter One, 896 F.Supp.2d 1 (D.D.C. 2012). Then, on March 31, 2015, the district court entered final judgment in the case. See Order at 2-5, United States Department of Justice v. Daniel Chapter One, No. 10-1362 (D.D.C. Mar. 31, 2015). Among other things, the district court’s final order: (1) permanently enjoined the defendants from advertising or selling any dietary supplement; (2) required the defendants to pay $1,345,832.43 in equitable monetary relief; and (3) required the defendants to pay $3,528,000 in civil penalties. The defendants now challenge the district court’s authority to order such relief.

The defendants first contend that the district court’s permanent injunction was [23]*23too broad. They argue that the court was limited to enjoining acts of the same “type or class” as those found to violate the law, which, in their view, means that the court should have gone no further than enjoining them from representing that any dietary supplement prevents, treats, or cures tumors and cancers. Appellants’ Br. 9-10 (citing Zenith Radio Corp. v. Hazeltine Research, Inc., 395 U.S. 100, 132, 89 S.Ct. 1562, 23 L.Ed.2d 129 (1969)). They also suggest that the court failed to consider that they had been “in compliance with the FTC Order since their contempt was purged on May 24, 2012, almost three years prior to the issuance of the expanded injunction.” Id. at 10.

We review the district court’s entry of a permanent injunction under the highly deferential abuse-of-discretion standard. See United States v. Philip Morris USA Inc., 566 F.3d 1095, 1110 (D.C. Cir. 2009). As this court has previously explained, “Since a district judge has wide latitude in fashioning a remedy, we will not disturb the trial court’s remedial choice unless there is no reasonable basis for the decision.” Securities & Exchange Commission v. First City Financial Corp., 890 F.2d 1215, 1228 (D.C. Cir. 1989).

The principal question in determining whether injunctive relief is appropriate is, as the district court noted in its opinion, whether there is a reasonable likelihood of future violations. See United States Department of Justice v. Daniel Chapter One, 89 F.Supp.3d 132, 143 (D.D.C. 2015) (citing, inter alia, NLRB v. Express Publishing Co., 312 U.S. 426, 436-37, 61 S.Ct. 693, 85 L.Ed. 930 (1941)); see also Philip Morris, 566 F.3d at 1132 (“To obtain equitable remedies, the government must demonstrate a reasonable likelihood of further violations in the future.” (internal quotation marks and alteration omitted)). The principal focus in fashioning an injunction is on preventing future violations of the type previously committed. See Aviation Consumer Action Project v. Washburn, 535 F.2d 101, 108 (D.C. Cir. 1976).

Here, in broadening the scope of its injunction upon entry of final judgment, the district court emphasized the defendants’ repeated and flagrant disregard for the Commission’s cease-and-desist order, this court’s order pendent lite, and its own preliminary injunction order. In particular, it stressed that:

From April 2, 2010, when the FTC Order went into effect, until May 24, 2012, when the defendants came into compliance with the FTC Order, the defendants intentionally and knowingly violated the FTC Order. From November 22, 2010, when the D.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sabra v. Pompeo
District of Columbia, 2020

Cite This Page — Counsel Stack

Bluebook (online)
650 F. App'x 20, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-department-of-justice-v-daniel-chapter-one-cadc-2016.